Three new 24-membered macrolactines, amylomacrolactines A–C (1–3), along with two known compounds 4 and 5, were isolated from the Arctic bacteria Bacillus amyloliquefaciens SCSIO 41392. The configurations of 1–3 were assigned by a combination of coupling constants, NOESY, and analysis of MM2-optimized conformation, as well as by comparison with reports in the literature. Compounds 1 and 2 showed quorum sensing (QS) inhibitory activities against the Pseudomonas aeruginosa (P. aeruginosa) PQS system and suppressed PQS-regulated virulence factor pyocyanin synthesis. In addition, compounds 3–5 affected the production of another essential virulence factor, siderophore of pyoverdine (PVD), in P. aeruginosa. More importantly, compound 5 showed an anti-biofilm activity against P. aeruginosa. Altogether, the isolated compounds displayed multiple bacterial virulence inhibition activities, which is worthy of further exploration for novel analogues in antimicrobial drug development.
Pantoea piersonii (formerly Kalamiella piersonii) is a recently reclassified environmental Gram-negative bacterium belonging to the family Erwiniaceae. Human infections caused by this organism are extremely rare. Here, we report a rare case of implantable venous access port-associated soft tissue infection caused by P. piersonii in a 49-year-old immunocompromised woman with lung cancer. The pathogen was isolated from purulent discharge obtained from the port site and identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). Whole-genome sequencing confirmed species-level identification based on average nucleotide identity (ANI) analysis and phylogenomic reconstruction. The isolate exhibited broad antimicrobial susceptibility to the tested agents. Following complete device removal and empirical antimicrobial therapy, the patient recovered uneventfully. This study reports the first documented case of P. piersonii infection in China and provides a comprehensive clinical and genomic characterization of a newly isolated clinical strain.